Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ACE | P12821 | 3/20 | 0.58 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.56 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.56 |
| ▸ | ITGAL | P20701 | 3/20 | 0.56 |
| ▸ | MMP2 | P08253 | 1/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | APAF1 | O14727 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | MPO | P05164 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6010119 | 1.00 | SMN1; SMN2 (0.60) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| Hydrochloric Acid SCHEMBL6010113 | 0.99 | SMN1; SMN2 (0.59) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| Hydrochloric Acid SCHEMBL6010121 | 0.99 | SMN1; SMN2 (0.59) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| SCHEMBL9924202 | 0.89 | ALOX15 (0.61) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| SCHEMBL8710928 | 0.89 | SMN1; SMN2 (0.68) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| SCHEMBL8710933 | 0.89 | SMN1; SMN2 (0.68) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| SCHEMBL28475095 | 0.87 | SMN1; SMN2 (0.56) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| SCHEMBL28475091 | 0.87 | SMN1; SMN2 (0.56) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| SCHEMBL11589471 | 0.86 | ACE (0.65) | SMN1; SMN2ALOX15ACEITGB2ICAM1 | |
| SCHEMBL28973296 | 0.86 | ACE (0.65) | SMN1; SMN2ALOX15ACEITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | SEIWA KASEI COMPANY, LIMITED (JP) | 2006-01-26 | — | — | US | disclosed |
| EP-1584320-A1 | COSMETIC PREPARATION CONTAINING GLYCERYLAMINO ACID DERIVATIVE | Seiwa Kasei Company, Limited (JP) | 2005-10-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018864-A1 | Cosmetic preparation containing glycerylamino acid derivative | GLA, GPKOW, CUTA | SMN1; SMN2 3951/4885ALOX15 2124/4885ACE 4053/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.